FDA Approved: RIFAMPIN — Supplemental Application (Chartwell RX, LLC)

View source ↗

Summary

The FDA approved a supplemental application for Rifampin (RIFAMPIN) submitted by Chartwell RX, LLC under ANDA065390.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hansen Disease
• Latent Tuberculosis Infection
• Meningococcal Disease
• Tuberculosis

Drugs mentioned

• RIFAMPIN (RIFAMPIN)

Snippet

SUPPL AP for RIFAMPIN (RIFAMPIN)